Dr Anne E Roberge, - Medicare Hematology/oncology in Weymouth, MA

Dr Anne E Roberge, is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Weymouth, Massachusetts. She went to Columbia University College Of Physicians And Surgeons and graduated in 1989 and has 35 years of diverse experience with area of expertise as Hematology/oncology. She is a member of the group practice Dana-farber Cancer Institute, Inc. and her current practice location is 101 Columbian St, Weymouth, Massachusetts. You can reach out to her office (for appointments etc.) via phone at (781) 624-5000.

Dr Anne E Roberge is licensed to practice in Massachusetts (license number 81605) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1639115041.

Contact Information

Dr Anne E Roberge,
101 Columbian St,
Weymouth, MA 02190
(781) 624-5000
(781) 624-4840



Physician's Profile

Full NameDr Anne E Roberge
GenderFemale
SpecialityHematology/oncology
Experience35 Years
Location101 Columbian St, Weymouth, Massachusetts
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Anne E Roberge attended and graduated from Columbia University College Of Physicians And Surgeons in 1989
  NPI Data:
  • NPI Number: 1639115041
  • Provider Enumeration Date: 06/22/2006
  • Last Update Date: 01/31/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 9739197740
  • Enrollment ID: I20060403000624

Medical Identifiers

Medical identifiers for Dr Anne E Roberge such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1639115041NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RH0003XInternal Medicine - Hematology & Oncology 81605 (Massachusetts)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
South Shore HospitalSouth weymouth, MAHospital
Brigham And Women's HospitalBoston, MAHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Dana-farber Cancer Institute, Inc.9133038904538

News Archive

Simulator helps stroke patients learn to drive again

A high-fidelity simulator that allows people to practice driving on a computer-generated course can help stroke patients learn to drive again, researchers have found.

School-provided lunches could be a solution to better childhood nutrition

Packing a lunchbox with fruit, sandwiches, and snacks is common practice for most Australian families. But what if there was another way?

Gene Biodesign joins Roche NimbleGen Certified Service Provider Program

Roche NimbleGen announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.

Emory University researchers develop experimental clinical test for XMRV

The recently discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been identified in some prostate cancer patients. In light of conflicting data concerning XMRV, standardized diagnostic testing is important to identify patients in which XMRV is present and to determine whether it plays a role in the incidence of prostate cancer.

Read more Medical News

› Verified 8 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Anne E Roberge allows following entities to bill medicare on her behalf.
Entity NameDana-farber Cancer Institute, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1346433257
PECOS PAC ID: 9133038904
Enrollment ID: O20040223000142

News Archive

Simulator helps stroke patients learn to drive again

A high-fidelity simulator that allows people to practice driving on a computer-generated course can help stroke patients learn to drive again, researchers have found.

School-provided lunches could be a solution to better childhood nutrition

Packing a lunchbox with fruit, sandwiches, and snacks is common practice for most Australian families. But what if there was another way?

Gene Biodesign joins Roche NimbleGen Certified Service Provider Program

Roche NimbleGen announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.

Emory University researchers develop experimental clinical test for XMRV

The recently discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been identified in some prostate cancer patients. In light of conflicting data concerning XMRV, standardized diagnostic testing is important to identify patients in which XMRV is present and to determine whether it plays a role in the incidence of prostate cancer.

Read more Medical News

› Verified 8 days ago

Entity NameDana-farber Cancer Institute, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1851333686
PECOS PAC ID: 9133038904
Enrollment ID: O20040223000228

News Archive

Simulator helps stroke patients learn to drive again

A high-fidelity simulator that allows people to practice driving on a computer-generated course can help stroke patients learn to drive again, researchers have found.

School-provided lunches could be a solution to better childhood nutrition

Packing a lunchbox with fruit, sandwiches, and snacks is common practice for most Australian families. But what if there was another way?

Gene Biodesign joins Roche NimbleGen Certified Service Provider Program

Roche NimbleGen announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.

Emory University researchers develop experimental clinical test for XMRV

The recently discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been identified in some prostate cancer patients. In light of conflicting data concerning XMRV, standardized diagnostic testing is important to identify patients in which XMRV is present and to determine whether it plays a role in the incidence of prostate cancer.

Read more Medical News

› Verified 8 days ago

Entity NameCoastal Medical Associates
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1932175684
PECOS PAC ID: 7113029257
Enrollment ID: O20070221000057

News Archive

Simulator helps stroke patients learn to drive again

A high-fidelity simulator that allows people to practice driving on a computer-generated course can help stroke patients learn to drive again, researchers have found.

School-provided lunches could be a solution to better childhood nutrition

Packing a lunchbox with fruit, sandwiches, and snacks is common practice for most Australian families. But what if there was another way?

Gene Biodesign joins Roche NimbleGen Certified Service Provider Program

Roche NimbleGen announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.

Emory University researchers develop experimental clinical test for XMRV

The recently discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been identified in some prostate cancer patients. In light of conflicting data concerning XMRV, standardized diagnostic testing is important to identify patients in which XMRV is present and to determine whether it plays a role in the incidence of prostate cancer.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Anne E Roberge is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Anne E Roberge,
101 Columbian St,
Weymouth, MA 02190-1601

Ph: (781) 624-5000
Dr Anne E Roberge,
101 Columbian St,
Weymouth, MA 02190

Ph: (781) 624-5000

News Archive

Simulator helps stroke patients learn to drive again

A high-fidelity simulator that allows people to practice driving on a computer-generated course can help stroke patients learn to drive again, researchers have found.

School-provided lunches could be a solution to better childhood nutrition

Packing a lunchbox with fruit, sandwiches, and snacks is common practice for most Australian families. But what if there was another way?

Gene Biodesign joins Roche NimbleGen Certified Service Provider Program

Roche NimbleGen announced today that Taipei-based genomic services provider Gene Biodesign Enterprises Co. has officially joined the Roche NimbleGen Certified Service Provider (CSP) Program.

Emory University researchers develop experimental clinical test for XMRV

The recently discovered retrovirus, xenotropic murine leukemia virus-related virus (XMRV), has been identified in some prostate cancer patients. In light of conflicting data concerning XMRV, standardized diagnostic testing is important to identify patients in which XMRV is present and to determine whether it plays a role in the incidence of prostate cancer.

Read more News

› Verified 8 days ago


Internal Medicine Doctors in Weymouth, MA

Todd Alan Kerensky, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 55 Fogg Road, Weymouth, MA 02190
Phone: 781-624-8000    Fax: 781-878-6750
Ronald W Dunlap, M.D.
Hematology & Oncology
Medicare: Not Enrolled in Medicare
Practice Location: 70 Pleasant St, South Shore Cardiology, Weymouth, MA 02190
Phone: 781-331-2000    
Dr. Sveta Shah Oza, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 90 Libbey Pkwy, Weymouth, MA 02189
Phone: 781-331-2922    Fax: 781-682-0611
Dr. Matthew D Giangola, M.D.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 55 Fogg Road, Weymouth, MA 02190
Phone: 781-792-4136    Fax: 781-878-6750
Leonid D Shturman, D.O.
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 90 Libbey Industrial Pkwy, Weymouth, MA 02189
Phone: 781-682-0610    Fax: 781-682-0611
Vitaly E Ermolin, MD
Hematology & Oncology
Medicare: Accepting Medicare Assignments
Practice Location: 55 Fogg Rd, Weymouth, MA 02190
Phone: 781-624-8000    Fax: 781-878-6750
Michael J Anderson, M.D.
Hematology & Oncology
Medicare: Medicare Enrolled
Practice Location: 51 Performance Dr, Suite 110, Weymouth, MA 02189
Phone: 781-340-0735    Fax: 781-331-6355

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.